Cargando…

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial

Although some intravenous drugs have been used to treat coronavirus disease 2019 (COVID-19), no effective antiviral agents are currently available in the outpatient setting. We aimed to evaluate the efficacy and adverse events of 14-day ciclesonide treatment vs. standard care for patients with mild-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Joon-Young, Yoon, Jin-Gu, Seo, Yu-Bin, Lee, Jacob, Eom, Joong-Sik, Lee, Jin-Soo, Choi, Won-Suk, Lee, Eun-Young, Choi, Young-Ah, Hyun, Hak-Jun, Seong, Hye, Noh, Ji-Yun, Cheong, Hee-Jin, Kim, Woo-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396813/ https://www.ncbi.nlm.nih.gov/pubmed/34441840 http://dx.doi.org/10.3390/jcm10163545

Ejemplares similares

Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma
por: Jamaati, Hamidreza, et al.
Publicado: (2015)

Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021)

Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis
por: Park, Hyung Jun, et al.
Publicado: (2022)

From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
por: Nave, Ruediger, et al.
Publicado: (2013)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
por: Terada-Hirashima, Junko, et al.
Publicado: (2020)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
por: Brodin, Daniel, et al.
Publicado: (2023)

Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases
por: Iwabuchi, Keisuke, et al.
Publicado: (2020)

Effect of internet-based vs. in-person multimodal interventions on patients with mild to moderate Alzheimer’s disease: a randomized, cross-over, open-label trial
por: Jung, Young Hee, et al.
Publicado: (2023)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room
por: Martins, Demétrius Tierno, et al.
Publicado: (2022)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
por: Choi, Min Joo, et al.
Publicado: (2021)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Ciclesonide: Oral candidiasis following off-label use: case report
Publicado: (2021)

Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015)

Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial
por: Ezer, Nicole, et al.
Publicado: (2021)

Laboratory Surveillance of Influenza-Like Illness in Seven Teaching Hospitals, South Korea: 2011–2012 Season
por: Noh, Ji Yun, et al.
Publicado: (2013)

Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer
por: Boss, H., et al.
Publicado: (2010)

Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study
por: Kuo, Kuan-Chih, et al.
Publicado: (2022)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study
por: Chiu, Kuo-Chin, et al.
Publicado: (2014)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

Clinical performance of the Sofia™ Influenza A + B FIA in adult patients with influenza-like illness
por: Noh, Ji Yun, et al.
Publicado: (2015)

Molecular genetic characteristics of influenza A virus clinically isolated during 2011‐2016 influenza seasons in Korea
por: Lee, Han Sol, et al.
Publicado: (2018)

Protection and Response of a Tertiary Hospital in South Korea to the COVID-19 Outbreak
por: Shi, Hye Jin, et al.
Publicado: (2020)

The Clinical Usefulness of the SD Bioline Influenza Antigen Test® for Detecting the 2009 Influenza A (H1N1) Virus
por: Choi, Won Suk, et al.
Publicado: (2011)

LC(50) Determination of tert-Butyl Acetate using a Nose Only Inhalation Exposure in Rats
por: Yang, Young-Su, et al.
Publicado: (2010)

Effectiveness of Regdanvimab at Preventing the Need for Oxygen Therapy in Patients with Mild-to-Moderate COVID-19: A Retrospective Cohort Study
por: Choi, Seong Jin, et al.
Publicado: (2022)

Risk factors differentiating mild/moderate from severe meconium aspiration syndrome in meconium-stained neonates
por: Choi, Woneui, et al.
Publicado: (2015)

Changes in the Expression of Ras-family Genes in Rats Exposed to Formaldehyde by Inhalation
por: Li, Guang-Yong, et al.
Publicado: (2008)

Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration
por: Noh, Ji Yun, et al.
Publicado: (2020)

Effect of High Dose Inhaled Glucocorticoids on Quality of Life in Patients with Moderate to Severe Asthma
por: Choi, Jae-Sung, et al.
Publicado: (2005)

A Comparison of the Clinical and Epidemiological Characteristics of Adult Patients with Laboratory-Confirmed Influenza A or B during the 2011–2012 Influenza Season in Korea: A Multi-Center Study
por: Wie, Seong-Heon, et al.
Publicado: (2013)

Acute Respiratory Distress Due to Methane Inhalation
por: Jo, Jun Yeon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ogbcoibrvjgam55cag0olbqfno